메뉴 건너뛰기




Volumn 35, Issue 3, 2016, Pages 330-345

KRYPTOR-automated angiogenic factor assays and risk of preeclampsia-related adverse outcomes

Author keywords

Adverse maternal and perinatal outcomes; angiogenic factors; hypertension; KRYPTOR assay; proteinuria; suspected preeclampsia; triage

Indexed keywords

PLACENTAL GROWTH FACTOR; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER; FLT1 PROTEIN, HUMAN;

EID: 84961878392     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2016.1148162     Document Type: Article
Times cited : (38)

References (25)
  • 3
    • 0029008174 scopus 로고
    • Neonatal outcome after preterm delivery for preeclampsia
    • discussion 8-92
    • S.A.Friedman, Schiff E, Kao L, B.M.Sibai Neonatal outcome after preterm delivery for preeclampsia. Am J Obstetrics Gynecol. 1995;172(6):1785–1788; discussion 8-92.
    • (1995) Am J Obstetrics Gynecol , vol.172 , Issue.6
    • Friedman, S.A.1    Schiff, E.2    Kao, L.3    Sibai, B.M.4
  • 4
    • 79959507759 scopus 로고    scopus 로고
    • Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease
    • C.E.Powe, R.J.Levine, S.A.Karumanchi Preeclampsia, a disease of the maternal endothelium:the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation. 2011;123(24):2856–2869.
    • (2011) Circulation , vol.123 , Issue.24 , pp. 2856-2869
    • Powe, C.E.1    Levine, R.J.2    Karumanchi, S.A.3
  • 5
    • 84857634410 scopus 로고    scopus 로고
    • Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy
    • U.Perni, C.Sison, V.Sharma, et al. Angiogenic factors in superimposed preeclampsia:a longitudinal study of women with chronic hypertension during pregnancy. Hypertension. 2012;59(3):740–746.
    • (2012) Hypertension , vol.59 , Issue.3 , pp. 740-746
    • Perni, U.1    Sison, C.2    Sharma, V.3
  • 6
    • 84871753612 scopus 로고    scopus 로고
    • Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers
    • A.Rolfo, R.Attini, A.M.Nuzzo, et al. Chronic kidney disease may be differentially diagnosed from preeclampsia by serum biomarkers. Kidney Int. 2013;83(1):177–181.
    • (2013) Kidney Int , vol.83 , Issue.1 , pp. 177-181
    • Rolfo, A.1    Attini, R.2    Nuzzo, A.M.3
  • 7
    • 77950815065 scopus 로고    scopus 로고
    • The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome
    • B.Young, R.J.Levine, S.Salahuddin, et al. The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J Maternal-fetal Neonatal Med. 2010;23(5):366–370.
    • (2010) J Maternal-fetal Neonatal Med , vol.23 , Issue.5 , pp. 366-370
    • Young, B.1    Levine, R.J.2    Salahuddin, S.3
  • 8
    • 84455208308 scopus 로고    scopus 로고
    • The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
    • 1
    • S.Verlohren, Herraiz I, O.Lapaire, et al. The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstetrics Gynecol. 2012;206(1):58 e1–e8.
    • (2012) Am J Obstetrics Gynecol , vol.206 , pp. 58 e1-e8
    • Verlohren, S.1    Herraiz, I.2    Lapaire, O.3
  • 9
    • 84857594613 scopus 로고    scopus 로고
    • Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia
    • S.Rana, C.E.Powe, S.Salahuddin, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation. 2012;125(7):911–919.
    • (2012) Circulation , vol.125 , Issue.7 , pp. 911-919
    • Rana, S.1    Powe, C.E.2    Salahuddin, S.3
  • 10
    • 84890527002 scopus 로고    scopus 로고
    • Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study
    • T.Chaiworapongsa, R.Romero, K.SJKorzeniewski, et al. Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area:a prospective study. J Maternal-fetal Neonatal Med. 2014;27(2):132–144.
    • (2014) J Maternal-fetal Neonatal Med , vol.27 , Issue.2 , pp. 132-144
    • Chaiworapongsa, T.1    Romero, R.2    Sj, K.3
  • 11
    • 84870382987 scopus 로고    scopus 로고
    • Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia
    • A.G.Moore, H.Young, J.M.Keller, et al. Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia. J Maternal-fetal Neonatal Med. 2012;25(12):2651–2657.
    • (2012) J Maternal-fetal Neonatal Med , vol.25 , Issue.12 , pp. 2651-2657
    • Moore, A.G.1    Young, H.2    Keller, J.M.3
  • 12
    • 84887145992 scopus 로고    scopus 로고
    • Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study
    • L.C.Chappell, S.Duckworth, P.T.Seed, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia:a prospective multicenter study. Circulation. 2013;128(19):2121–2131.
    • (2013) Circulation , vol.128 , Issue.19 , pp. 2121-2131
    • Chappell, L.C.1    Duckworth, S.2    Seed, P.T.3
  • 13
    • 10744227199 scopus 로고    scopus 로고
    • Circulating angiogenic factors and the risk of preeclampsia
    • R.J.Levine, S.E.Maynard, C.Qian, et al. Circulating angiogenic factors and the risk of preeclampsia. New England J Med. 2004;350(7):672–683.
    • (2004) New England J Med , vol.350 , Issue.7 , pp. 672-683
    • Levine, R.J.1    Maynard, S.E.2    Qian, C.3
  • 14
    • 3442884269 scopus 로고    scopus 로고
    • Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia
    • discussion, 7-50
    • T.Chaiworapongsa, R.Romero, J.Espinoza, et al. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Am J Obstetrics Gynecol. 2004;190(6):1541–1547; discussion 7-50.
    • (2004) Am J Obstetrics Gynecol , vol.190 , Issue.6 , pp. 1541-1547
    • Chaiworapongsa, T.1    Romero, R.2    Espinoza, J.3
  • 15
    • 20244362656 scopus 로고    scopus 로고
    • Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia
    • T.Chaiworapongsa, R.Romero, Y.M.Kim, et al. Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Maternal-fetal Neonatal Med. 2005;17(1):3–18.
    • (2005) J Maternal-fetal Neonatal Med , vol.17 , Issue.1 , pp. 3-18
    • Chaiworapongsa, T.1    Romero, R.2    Kim, Y.M.3
  • 16
    • 33748421660 scopus 로고    scopus 로고
    • Soluble endoglin and other circulating antiangiogenic factors in preeclampsia
    • R.J.Levine, C.Lam, C.Qian, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. New England J Med. 2006;355(10):992–1005.
    • (2006) New England J Med , vol.355 , Issue.10 , pp. 992-1005
    • Levine, R.J.1    Lam, C.2    Qian, C.3
  • 17
    • 77955417702 scopus 로고    scopus 로고
    • Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension
    • M.Noori, A.E.Donald, A.Angelakopoulou, A.D.Hingorani, D.J.Williams Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation. 2010;122(5):478–487.
    • (2010) Circulation , vol.122 , Issue.5 , pp. 478-487
    • Noori, M.1    Donald, A.E.2    Angelakopoulou, A.3    Hingorani, A.D.4    Williams, D.J.5
  • 18
    • 75049083263 scopus 로고    scopus 로고
    • An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia
    • S.Verlohren, A.Galindo, D.Schlembach, et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstetrics Gynecol. 2010;202(2):161 e1–161 e11.
    • (2010) Am J Obstetrics Gynecol , vol.202 , Issue.2 , pp. 161 e1-161 e11
    • Verlohren, S.1    Galindo, A.2    Schlembach, D.3
  • 19
    • 72149103278 scopus 로고    scopus 로고
    • Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study
    • S.Sunderji, E.Gaziano, D.Wothe, et al. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia:a prospective clinical study. Am J Obstetrics Gynecol. 2010;202(1):40 e1–40 e7.
    • (2010) Am J Obstetrics Gynecol , vol.202 , Issue.1
    • Sunderji, S.1    Gaziano, E.2    Wothe, D.3
  • 20
    • 80255122679 scopus 로고    scopus 로고
    • Angiogenic factors as diagnostic tests for preeclampsia: a performance comparison between two commercial immunoassays
    • S.J.Benton, Y.Hu, F.Xie, et al. Angiogenic factors as diagnostic tests for preeclampsia:a performance comparison between two commercial immunoassays. Am J Obstetrics Gynecol. 2011;205(5):469 e1–469 e8.
    • (2011) Am J Obstetrics Gynecol , vol.205 , Issue.5 , pp. 469 e1-469 e8
    • Benton, S.J.1    Hu, Y.2    Xie, F.3
  • 21
    • 77952953001 scopus 로고    scopus 로고
    • Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia
    • J.Schiettecatte, H.Russcher, E.Anckaert, et al. Multicenter evaluation of the first automated Elecsys sFlt-1 and PlGF assays in normal pregnancies and preeclampsia. Clin Biochem. 2010;43:768–770.
    • (2010) Clin Biochem , vol.43 , pp. 768-770
    • Schiettecatte, J.1    Russcher, H.2    Anckaert, E.3
  • 22
    • 84947026504 scopus 로고    scopus 로고
    • Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia
    • J.van Helden, R.Weiskirchen Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia. Clin Biochem. 2015;48:1113–1119.
    • (2015) Clin Biochem , vol.48 , pp. 1113-1119
    • van Helden, J.1    Weiskirchen, R.2
  • 23
    • 84924610195 scopus 로고    scopus 로고
    • Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio: an inter-assay comparison
    • L.B.Andersen, B.Frederiksen-Moller, K.Work Havelund, et al. Diagnosis of preeclampsia with soluble Fms-like tyrosine kinase 1/placental growth factor ratio:an inter-assay comparison. J Am Soc Hypertens. 2015;9(2):86–96.
    • (2015) J Am Soc Hypertens , vol.9 , Issue.2 , pp. 86-96
    • Andersen, L.B.1    Frederiksen-Moller, B.2    Work Havelund, K.3
  • 24
    • 84892393113 scopus 로고    scopus 로고
    • Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy
    • 5
    • American College of O, Gynecologists, and Task Force on Hypertension in P. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstetrics Gynecol. 2013;122(5):1122–1131.
    • (2013) Obstetrics Gynecol , vol.122 , pp. 1122-1131
  • 25
    • 77951945121 scopus 로고    scopus 로고
    • Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia
    • A.Ohkuchi, C.Hirashima, H.Suzuki, et al. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia. Hypertens Res. 2010;33(5):422–427
    • (2010) Hypertens Res , vol.33 , Issue.5 , pp. 422-427
    • Ohkuchi, A.1    Hirashima, C.2    Suzuki, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.